BRCA1 and ovarian cancer: There are, relatively, many reports that BRCA carriers with common founder mutations have different risks of developing breast and ovarian cancer compared with the overall BRCA1/2 mutation, however, the results of only a few common founder mutations have been validated by multiple studies.